Continue reading this on our app for a better experience

Open in App
Floating Button
Home News Company in the news

Medtecs to apply for transfer to SGX-ST Mainboard; to join MSCI Singapore Small Cap Index

Felicia Tan
Felicia Tan • 2 min read
Medtecs to apply for transfer to SGX-ST Mainboard; to join MSCI Singapore Small Cap Index
Shares in Medtecs closed 11 cents higher or 14.2% up at 88.5 cents on Nov 13.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Medtecs International says it intends to make an application to transfer its listing from the Catalist to the Mainboard of the Singapore Exchange Securities Trading Limited (SGX-ST) on Nov 16.

The proposed transfer, according to the company, would better place the company to attract institutional investors and reach out to a wider investor base in Singapore and overseas.

The company also believes the transfer to the Mainboard would “enhance its image” and provide it with “greater visibility and recognition in the market”, which is “particularly critical in this Covid-19 pandemic situation”.

The proposed transfer is subject to the in-principle approval of the SGX-ST, the company meeting the minimum requirements according to Mainboard Rule 210 where the company has to have a minimum consolidated pre-tax profit of at least $30 million for the latest financial year, and the approval of its shareholders, to be obtained at the next extraordinary general meeting (EGM).


See: Medtecs International dresses and protects global healthcare workers

On the same day, Medtecs announced its inclusion in the MSCI Singapore Small Cap Index with effect from Nov 30, after the close of market trading.

The Index is designed to measure the performance of the small cap segment in the Singapore market. It has 57 constituents as at Oct 30, and it represents some 14% of the free float-adjusted market capitalisation of the Singapore equity universe.

“The inclusion serves as a strong affirmation of our market leading position, and will bring about higher trading liquidity and visibility to investors globally,” says William Yang, executive director and CEO of Medtecs.

For more stories about where the money flows, click here for our Capital section

“Backed by our diversified regional production facilities and worldwide distribution capabilities, Medtecs is well-positioned to ride on the paradigm shift in global PPE as we capitalise on our niche positioning of global PPE manufacturing with our own Medtecs-branded products,” Yang adds.

Shares in Medtecs closed 11 cents higher or 14.2% up at 88.5 cents on Nov 13.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.